Kristina Burow
Sits on 6 boards. Overboarded · 6 public boards Last updated September 27, 2026
Time on boards
- Boards served
- 6
- Current seats
- 6
- Board service
- 16 years
- Director since
- 2023
16 years of board service in total across 6 boards, counting each seat separately. Longest: Beam Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neumora Therapeutics Inc. June 13, 202496.2%
-
Scholar Rock Holding Corporation June 21, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Scholar Rock Holding Corporation | Open-market sale | −2,105 | $53.49 | $112,605 |
| Jul 1, 2026 | Scholar Rock Holding Corporation | Open-market sale | −948 | $54.28 | $51,459 |
| Jun 4, 2026 | Scholar Rock Holding Corporation | Grant or award | +6,839 | — | — |
| Apr 23, 2026 | Scholar Rock Holding Corporation | Option exercise | +7,800 | $26.78 | $208,884 |
| Apr 23, 2026 | Scholar Rock Holding Corporation | Option exercise | +28,000 | $4.75 | $133,000 |
| Apr 23, 2026 | Scholar Rock Holding Corporation | Option exercise | +36,000 | $9.11 | $327,960 |
| Apr 23, 2026 | Scholar Rock Holding Corporation | Option exercise | +18,000 | $8.36 | $150,480 |
| Oct 27, 2025 | Neumora Therapeutics Inc. | Open-market purchase | +1,915,700 | $2.61 | $4,999,977 |
| May 29, 2025 | Scholar Rock Holding Corporation | Open-market sale | −1,000 | $29.24 | $29,240 |
| May 29, 2025 | Scholar Rock Holding Corporation | Open-market sale | −4,400 | $29.83 | $131,252 |
| May 22, 2025 | Scholar Rock Holding Corporation | Grant or award | +7,632 | — | — |
| Jun 27, 2024 | Scholar Rock Holding Corporation | Grant or award | +13,500 | — | — |
| Jun 13, 2024 | Neumora Therapeutics Inc. | Grant or award | +20,100 | — | — |
| Apr 2, 2024 | Boundless Bio Inc. | Derivative conversion | +589,743 | — | — |
| Apr 2, 2024 | Boundless Bio Inc. | Derivative conversion | +787,545 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.